SCHEMBL10107036

SCHEMBL10107036

COc1ccc(/C(C)=N/OCc2cc(F)cc(F)c2)cc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.43
LMNA P02545 1/20 0.42
PTBP1 P26599 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TUBB1 Q9H4B7 5/20 0.40
TUBB4A P04350 4/20 0.40
TUBB P07437 4/20 0.40
TUBA3C P0DPH7 4/20 0.40
TUBA1B P68363 4/20 0.40
TUBA4A P68366 4/20 0.40
TUBB4B P68371 4/20 0.40
TUBB3 Q13509 4/20 0.40
TUBB2A Q13885 4/20 0.40
TUBB8 Q3ZCM7 4/20 0.40
TUBA3E Q6PEY2 4/20 0.40
TUBA1A Q71U36 4/20 0.40
TUBA1C Q9BQE3 4/20 0.40
TUBB6 Q9BUF5 4/20 0.40
TUBB2B Q9BVA1 4/20 0.40
PDE4D Q08499 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10106925 0.90 SMN1; SMN2 (0.49) RECQLLMNAPTBP1SMN1; SMN2TUBB1
SCHEMBL10106852 0.89 PTPN7 (0.46) RECQLLMNAPTBP1SMN1; SMN2TUBB1
SCHEMBL10107226 0.85 MAOA (0.42) RECQLLMNATUBB1TUBB4ATUBB
SCHEMBL10102056 0.84 SMN1; SMN2 (0.44) LMNAPTBP1SMN1; SMN2PPARGPPARA
SCHEMBL15255539 0.84 NPC1 (0.48) RECQLLMNASMN1; SMN2TUBB1TUBB4A
SCHEMBL10106877 0.83 GAA (0.46) RECQLLMNASMN1; SMN2TUBB1TUBB4A
SCHEMBL10107287 0.81 MAOB (0.43) RECQLLMNAPTBP1SMN1; SMN2TUBB1
SCHEMBL10106911 0.80 PDE4D (0.45) RECQLLMNAPDE4DPDE4APDE4B
SCHEMBL10106822 0.80 TUBB4A (0.42) RECQLLMNASMN1; SMN2TUBB1TUBB4A
SCHEMBL10106910 0.80 NPC1 (0.46) RECQLTUBB1TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed
WO-2008124878-A1 NON-STEROIDAL COMPOUNDS CRYPTOPHARMA PTY LTD (AU) 2008-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 RECQL 3871/4885LMNA 2636/4885PTBP1 2831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.